| [1] |
World Health Organization. Report of the WHO－China joint mission on coronavirus disease 2019 (COVID－19) [EB/OL]. 2020:
URL
|
| [2] |
中华人民共和国卫生健康委员会. 截至5月25日24时新型冠状病毒肺炎疫情最新情况[EB/OL]. 2020：
URL
|
| [3] |
Rismanbaf A, Zarei S. Liver and kidney injuries in covid－19 and their effects on drug therapy, a letter to editor [J]. Arch Acad Emerg Med, 2020, 8(1): e17.
|
| [4] |
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus－infected pneumonia [J]. N Engl J Med, 2020, 382(13): 1199-1207.
|
| [5] |
Sanche S, Lin YT, Xu C, et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2 [J]. Emerg Infect Dis, 2020, 26(7): 1470-1477.
|
| [6] |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus－infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
|
| [7] |
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China [J]. N Engl J Med, 2020, 382(18): 1708-1720.
|
| [8] |
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in－hospital death of patients with COVID－19 [J]. Kidney Int, 2020, 97(5): 829-838.
|
| [9] |
Anti－2019－nCoV Volunteers, Li Z, Wu M, et al. Caution on kidney dysfunctions of covid－19 patients [J]. medRxiv, 2020, [https：// doi.org/ 10.1101/ 2020. 02. 08.20021212]．
|
| [10] |
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS－CoV－2 pneumonia in Wuhan, China: a single－centered, retrospective, observational study [J]. Lancet Respir Med, 2020, 8 (5): 475-481.
|
| [11] |
Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID－19 [J]. Kidney Int, 2020, 98(1): 209-218.
|
| [12] |
Wang L, Li X, Chen H, et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China [J]. Am J Nephrol, 2020, 51(5): 343-348.
|
| [13] |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
|
| [14] |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]. Lancet, 2020, 395(10223): 507-513.
|
| [15] |
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [J]. JAMA Intern Med, 2020，[published online ahead of print].
|
| [16] |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID－19 associated with acute respiratory distress syndrome [J]. Lancet Respir Med, 2020, 8(4): 420-422.
|
| [17] |
姚小红，李廷源，何志承，等．新型冠状病毒肺炎(COVID－19)三例遗体多部位穿刺组织病理学研究 [J]. 中华病理学杂志，2020, 49(05): 411-417.
|
| [18] |
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-273.
|
| [19] |
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J]. Lancet, 2020, 395(10224): 565-574.
|
| [20] |
Hoffmann M, Kleine－Weber H, Krüger N, et al. The novel coronavirus 2019 (2019－nCoV) uses the SARS－coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells [J]. bioRxiv, 2020, [https：//doi.org/10.1101/2020.01.31.929042]．
|
| [21] |
Zou X, Chen K, Zou J, et al. Single－cell RNA－seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019－nCoV infection [J]. Front Med, 2020, 14 (2): 185-192.
|
| [22] |
Pan XW, Xu D, Zhang H, et al. Identification of a potential mechanism of acute kidney injury during the COVID－19 outbreak: a study based on single－cell transcriptome analysis [J]. Intensive Care Med, 2020, 46(6): 1114-1116.
|
| [23] |
Ronco C, Reis T. Kidney involvement in COVID－19 and rationale for extracorporeal therapies [J]. Nat Rev Nephrol, 2020, 16(6): 308-310.
|
| [24] |
Chena G, Zhou YZ, Ma J, et al. Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID－19 patients? [J]. Ren Fail, 2020, 42(1): 483-488.
|
| [25] |
Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID－19 associated pneumonia in clinical studies [J]. Biosci Trends, 2020, 14(1): 72-73.
|
| [26] |
Yang Y, Shi J, Ge S, et al. Effect of continuous renal replacement therapy on all－cause mortality in COVID－19 patients undergoing invasive mechanical ventilation: a retrospective cohort study [J]. medRxiv, 2020, [https：// doi.org/ 10.1101/2020.03.16.20036780]．
|
| [27] |
Liu Y, Sun W, Li J, et al. Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019 [J]. medRxiv, 2020, [https：//doi.org/10.1101/2020.02.17.20024166]．
|
| [28] |
Hatem A, Daoud A, Mohamed MM, et al. Survival rate in acute kidney injury superimposed COVID－19 patients: a systematic review and meta－analysis [J]. Ren Fail, 2020, 42(1): 393-397.
|